ACADIA Pharmaceuticals Inc
NASDAQ:ACAD

Watchlist Manager
ACADIA Pharmaceuticals Inc Logo
ACADIA Pharmaceuticals Inc
NASDAQ:ACAD
Watchlist
Price: 26.81 USD -0.3% Market Closed
Market Cap: 4.5B USD

Wall Street
Price Targets

ACAD Price Targets Summary
ACADIA Pharmaceuticals Inc

Wall Street analysts forecast ACAD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ACAD is 29.85 USD with a low forecast of 17.17 USD and a high forecast of 40.95 USD.

Lowest
Price Target
17.17 USD
36% Downside
Average
Price Target
29.85 USD
11% Upside
Highest
Price Target
40.95 USD
53% Upside
ACADIA Pharmaceuticals Inc Competitors:
Price Targets
BMEA
Biomea Fusion Inc
364% Upside
ARX
Aroa Biosurgery Ltd
31% Upside
IONS
Ionis Pharmaceuticals Inc
8% Upside
VITR
Vitrolife AB
37% Upside
PGEN
Precigen Inc
147% Upside
CDNA
CareDx Inc
20% Upside
MDXG
MiMedx Group Inc
78% Upside
688235
Beigene Ltd
35% Upside

Revenue
Forecast

Revenue Estimate
ACADIA Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
ACADIA Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
ACADIA Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ACAD's stock price target?
Price Target
29.85 USD

According to Wall Street analysts, the average 1-year price target for ACAD is 29.85 USD with a low forecast of 17.17 USD and a high forecast of 40.95 USD.

Back to Top